Single-Session Ablative Transarterial Radioembolization for Patients with Hepatocellular Carcinoma to Streamline Care: An Initial Experience
CardioVascular and Interventional Radiology · 2024-09 · 47 (9) · 1239-1245
DOI: 10.1007/s00270-024-03799-6 ↗Kurz gefasst
Fachartikel in der Zeitschrift CardioVascular and Interventional Radiology, online erschienen am 08.07.2024. Verfasst von Zachary T Berman und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Vascular and Interventional Radiology, Department of Radiology, University of California, 200 West Arbor Dr, San Diego, California, 92103…. Hauptthemen laut MEDLINE: Liver Neoplasms, Carcinoma, Hepatocellular, Embolization, Therapeutic, Microspheres. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 13 Literaturangaben.
Abstract (Originalsprache)
PURPOSE: Transarterial radioembolization (TARE) for hepatocellular carcinoma (HCC) is performed after a mapping angiogram involving infusion of radiolabeled macroaggregated albumin to assess for non-target embolization and pulmonary shunting. The purpose of this case series was to evaluate the safety and feasibility of single-session TARE without the initial procedure. MATERIALS AND METHODS: A single-institution case series of 16 consecutive procedures on 15 patients with 18 tumors who underwent an attempted single-session TARE procedures with glass microspheres are presented. A lung shunt fraction (LSF) of 5% was assumed for planning purposes. RESULTS: Sixty-seven percent (10/15) of patients were male with a median age of 72 years. Median tumor size was 2.5 cm (IQR 2.0-3.2 cm). Sixteen of the 18 targeted tumors were untreated prior to the single-session TARE. Rate of technical success was 88% (14/16). Two patients did not ultimately receive a single-session TARE due to intraprocedural findings. The mean administered activity was 2.0 GBq, and the mean MIRD dose was 464 Gy based on pre-treatment anatomic imaging and 800 Gy based on cone-beam CT. There were no cases of radiation pneumonitis. Mean post-procedural calculated lung dose was 4.9 Gy (range 3.1-9.3) based on SPECT. CONCLUSIONS: An initial experience with single-session TARE using Y-90 glass microspheres without pre-procedural mapping angiography and lung shunt estimation demonstrates that it is a feasible and safe treatment option for select patients with small (< 5 cm) HCC. LEVEL OF EVIDENCE IV: Level 4 case series.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Vascular and Interventional Radiology, Department of Radiology, University of California, 200 West Arbor Dr, San Diego, California, 92103, USA. ZBerman@health.ucsd.edu.
- Division of Vascular and Interventional Radiology, Department of Radiology, University of California, 200 West Arbor Dr, San Diego, California, 92103, USA.
Zitieren
APA
Berman, Z. T., Pianka, K., Qaseem, Y., Redmond, J., & Minocha, J. (2024). Single-Session Ablative Transarterial Radioembolization for Patients with Hepatocellular Carcinoma to Streamline Care: An Initial Experience. CardioVascular and Interventional Radiology, 47(9), 1239-1245. https://doi.org/10.1007/s00270-024-03799-6
Vancouver
Berman ZT, Pianka K, Qaseem Y, Redmond J, Minocha J. Single-Session Ablative Transarterial Radioembolization for Patients with Hepatocellular Carcinoma to Streamline Care: An Initial Experience. CardioVascular and Interventional Radiology. 2024;47(9):1239-1245. doi:10.1007/s00270-024-03799-6
BibTeX
@article{Berman2024,
author = {Berman, Zachary T and Pianka, Kurt and Qaseem, Yousuf and Redmond, Jonas and Minocha, Jeet},
title = {Single-Session Ablative Transarterial Radioembolization for Patients with Hepatocellular Carcinoma to Streamline Care: An Initial Experience},
journal = {CardioVascular and Interventional Radiology},
year = {2024},
volume = {47},
number = {9},
pages = {1239--1245},
doi = {10.1007/s00270-024-03799-6}
}
EUVIMED